Evaluation of the pharmacogenetics of immune recovery in treated HIV-infected patients
Joaquim Peraire(Instituto de Salud Carlos III), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Cristóbal Richart(Universitat Rovira i Virgili), Peré Domingo(Hospital de Sant Pau), Consuelo Viladés(Hospital Universitario Fundación Jiménez Díaz), Isaac Rosado‐Sánchez(Instituto de Biomedicina de Sevilla), Miguel López-Dupla, Yolanda M. Pacheco(Instituto de Biomedicina de Sevilla), Mar Gutiérrez, Manuel Leal(Apple (Israel))
Cited by 10
Related Papers
Ultraviolet vision in lizards
|Nature|1993|257
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
|The Lancet Infectious Diseases|2015|143